Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17956-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- FUT1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated FUT1 antibody (Cat. #17956-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Fucosyltransferases Regulated by Fusobacterium Nucleatum and Act as Novel Biomarkers in Colon Adenocarcinoma.
2-D-gal Targets Terminal Fucosylation to Inhibit T-cell Response in a Mouse Skin Transplant Model.
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis.
poFUT1 promotes endometrial decidualization by enhancing the O-fucosylation of Notch1.
Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.
Wang P, Liu X, Yu J, Meng Z, Lv Z, Shang C, Geng Q, Wang D, Xue D, Li L
Journal of inflammation research 2023;16:747-768
Journal of inflammation research 2023;16:747-768
2-D-gal Targets Terminal Fucosylation to Inhibit T-cell Response in a Mouse Skin Transplant Model.
Mao K, Luo J, Ye J, Li L, Lin F, Zhou M, Wang D, Yu L, Zhu Z, Zuo D, Ye J
Transplantation 2023 Jun 1;107(6):1291-1301
Transplantation 2023 Jun 1;107(6):1291-1301
FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis.
Luo J, Mao K, Zhu Z, Ye J, Li L, Wang D, Zhou J, Lin F, Li J, Ye J
Molecular medicine (Cambridge, Mass.) 2023 Apr 21;29(1):55
Molecular medicine (Cambridge, Mass.) 2023 Apr 21;29(1):55
poFUT1 promotes endometrial decidualization by enhancing the O-fucosylation of Notch1.
Yang Y, Zhang D, Qin H, Liu S, Yan Q
EBioMedicine 2019 Jun;44:563-573
EBioMedicine 2019 Jun;44:563-573
Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.
Aziz F, Yang X, Wang X, Yan Q
Journal of cancer research and clinical oncology 2015 Jul;141(7):1221-35
Journal of cancer research and clinical oncology 2015 Jul;141(7):1221-35
No comments: Submit comment
No validations: Submit validation data